

Why Invest in EW2Health?
EW2Health is positioned at the intersection of digital health, obesity care, and the exploding GLP-1 market. Our predictive technology and certified ecosystem transform weight loss programs from transactional to sustainable — improving outcomes while delivering real, recurring revenue at scale.
Massive Market Need
-
$1.5T obesity burden, 2B people overweight
-
GLP-1 market growing ~20% annually
Unique Solution
-
Patented Predictive Behavioral Analytics (PBA)
-
Bridges medical treatment and lifestyle for sustainable results
Proven Impact
-
30% higher patient retention
-
5x better adherence
-
25% lower operational costs
Recurring Revenue Model
-
SaaS subscriptions (€15/patient/month)
-
Onboarding & training fees
-
Ecosystem revenues (devices, integrations)
Strong Traction
-
Paying customers and LOIs in EU, BR, UK
-
Scientifica collaboration in France
-
Major corporate wellness partners (e.g., Petrobras, WEG)
Experienced Team
-
Medical, AI, and business expertise
Clear Growth Plan
-
Break-even projected Q2 2027
-
6.5x expected valuation increase with next funding round